Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia

Kusum Sinha, Chichun Sun, Rashmi Kamari, Kerstin Bettermann

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Vascular dementia (VaD) is a progressive neurocognitive clinical syndrome that is caused by a decrease in cerebral blood flow and damage to the neurovascular unit. Given increasing life expectancy, VaD is emerging as one of the leading health problems in society. Despite the high global prevalence of cognitive impairment associated with VaD, diagnosis and treatment still remain limited because of the complexity of mechanisms of neuronal loss. Therefore, advances in our understanding of the pathophysiological mechanisms involved is crucial for the development of new therapeutic strategies. In this review, we highlight the pathophysiology, current pharmacology-based primary and secondary prevention strategies and emerging treatment options for VaD.

Original languageEnglish (US)
Pages (from-to)793-799
Number of pages7
JournalDrug Discovery Today
Volume25
Issue number4
DOIs
StatePublished - Apr 2020

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia'. Together they form a unique fingerprint.

Cite this